KORU Medical Systems to Participate in Canaccord Genuity's 42nd Annual Growth Conference
KORU Medical Systems to Participate in Canaccord Genuity's 42nd Annual Growth Conference
KORU Medical Systems (NASDAQ: KRMD) announced its participation in Canaccord Genuity's 42nd Annual Growth Conference, scheduled for August 10, 2022, at 10:00 AM ET.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
MAHWAH, N.J.--(BUSINESS WIRE)--
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the company will participate in Canaccord Genuity's 42nd Annual Growth Conference on August 10th, 2022.
KORU Medical's management is scheduled to present at the Canaccord Growth Conference on Wednesday, August 10th, 2022 at 10:00 AM ET.Interested parties can access the live and archived webcast on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.
